228 related articles for article (PubMed ID: 36625184)
1. Frizzled-7-targeting antibody (SHH002-hu1) potently suppresses non-small-cell lung cancer via Wnt/β-catenin signaling.
Li K; Mao S; Li X; Zhao H; Wang J; Wang C; Wu L; Zhang K; Yang H; Jin M; Zhou Z; Wang J; Huang G; Xie W
Cancer Sci; 2023 May; 114(5):2109-2122. PubMed ID: 36625184
[TBL] [Abstract][Full Text] [Related]
2. A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway.
Xie W; Zhao H; Wang F; Wang Y; He Y; Wang T; Zhang K; Yang H; Zhou Z; Shi H; Wang J; Huang G
J Exp Clin Cancer Res; 2021 Jan; 40(1):30. PubMed ID: 33436039
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
[TBL] [Abstract][Full Text] [Related]
4. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
5. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
Zhang Y; Zhang Q; Chen H; Wang C
Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
[TBL] [Abstract][Full Text] [Related]
6. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
[TBL] [Abstract][Full Text] [Related]
7. miR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt/β-catenin signaling pathway via regulating USP48.
Zhang P; Li L; Wang B; Ran X; Yang S; Luo Y; Li Y; Wang Z; Liu Y; Zhu B
Respir Res; 2022 Apr; 23(1):93. PubMed ID: 35413838
[TBL] [Abstract][Full Text] [Related]
8. LINC00514 facilitates cell proliferation, migration, invasion, and epithelial-mesenchymal transition in non-small cell lung cancer by acting on the Wnt/β-catenin signaling pathway.
Zhu Y; Wu H; Yang X; Xiong Z; Zhao T; Gan X
Bioengineered; 2022 May; 13(5):13654-13666. PubMed ID: 35653786
[TBL] [Abstract][Full Text] [Related]
9. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
[TBL] [Abstract][Full Text] [Related]
10. Histone demethylase PHF8 promotes cell growth and metastasis of non-small-cell lung cancer through activating Wnt/β-catenin signaling pathway.
Hu Y; Mu H; Yang Y
Histol Histopathol; 2021 Aug; 36(8):869-877. PubMed ID: 34100557
[TBL] [Abstract][Full Text] [Related]
11. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
12. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
[TBL] [Abstract][Full Text] [Related]
13. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
[TBL] [Abstract][Full Text] [Related]
15. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
[TBL] [Abstract][Full Text] [Related]
16. Dehydroeffusol inhibits hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer cells through the inactivation of Wnt/β-catenin pathway.
Wei H; Zhang F; Wang J; Zhao M; Hou T; Li L
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32426814
[TBL] [Abstract][Full Text] [Related]
17. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
Zhang Z; Xu Y
Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
[TBL] [Abstract][Full Text] [Related]
19. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer.
Wang B; Tang Z; Gong H; Zhu L; Liu X
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
